Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 01-2026 | 10-2025 | 07-2025 | 04-2025 | 01-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,575 | -8,278 | -26,556 | -18,392 | -12,167 |
| Depreciation Amortization | 53 | 27 | 107 | 80 | 53 |
| Accounts receivable | 98 | 888 | 734 | 733 | 643 |
| Accounts payable and accrued liabilities | -1,404 | -1,155 | -3,887 | -3,892 | -2,168 |
| Other Working Capital | -695 | 228 | -1,907 | -2,314 | -1,238 |
| Other Operating Activity | 1,851 | 586 | 3,340 | 3,746 | 2,001 |
| Operating Cash Flow | $-15,672 | $-7,705 | $-28,171 | $-20,038 | $-12,875 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,373 | N/A | -7,316 | N/A | N/A |
| Purchase Of Investment | -165 | -75 | -330 | -255 | -150 |
| Investing Cash Flow | $7,208 | $-75 | $-7,646 | $-255 | $-150 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 27,874 | N/A | 45,448 | 31,891 | 17,177 |
| Financing Cash Flow | $27,874 | $N/A | $45,448 | $31,891 | $17,177 |
| Beginning Cash Position | 10,494 | 10,494 | 862 | 862 | 862 |
| End Cash Position | 29,904 | 2,714 | 10,494 | 12,460 | 5,014 |
| Net Cash Flow | $19,410 | $-7,780 | $9,632 | $11,598 | $4,152 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,672 | -7,705 | -28,171 | -20,038 | -12,875 |
| Free Cash Flow | -15,672 | -7,705 | -28,171 | -20,038 | -12,875 |